MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Cardiovascular, Cardiac & Cardiology Companies
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO)*
Organization & Developments: Orchestra BioMed
Parents
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO)*
Children
*Two late-stage flagship technologies designed to address large unmet needs associated with the treatment of hypertension, a significant risk factor for death worldwide and atherosclerotic artery disease, the leading cause of mortality worldwide.
2025: Orchestra BioMed rises as trial for antihypertensive drug expands
2025: Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships
Jumps
Finance & Acquisitions: Orchestra BioMed
Key People: Orchestra BioMed